I 
115TH CONGRESS 
1ST SESSION H. R. 4333 
To provide for the issuance of a Lyme Disease Research Semipostal Stamp. 
IN THE HOUSE OF REPRESENTATIVES 
NOVEMBER 9, 2017 
Mr. FASO (for himself, Mr. PETERSON, Mrs. COMSTOCK, Ms. SHEA-PORTER, 
Ms. PINGREE, Mr. MOULTON, Ms. NORTON, Mr. BARLETTA, Mr. LANCE, 
Ms. STEFANIK, Mr. SEAN PATRICK MALONEY of New York, Mr. COHEN, 
Mr. KEATING, Mr. POCAN, Ms. LOFGREN, Mr. ESPAILLAT, Mr. KATKO, 
Mr. SMITH of New Jersey, Mr. KING of New York, Mr. COURTNEY, Mr. 
COLLINS of New York, Mr. ZELDIN, and Mr. DONOVAN) introduced the 
following bill; which was referred to the Committee on Oversight and 
Government Reform, and in addition to the Committee on Energy and 
Commerce, for a period to be subsequently determined by the Speaker, 
in each case for consideration of such provisions as fall within the juris-
diction of the committee concerned 
A BILL 
To provide for the issuance of a Lyme Disease Research 
Semipostal Stamp. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Lyme Disease Re-
search Stamp Act’’. 
VerDate Sep 11 2014 
23:06 Nov 15, 2017
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4333.IH
H4333
daltland on DSK30NT082PROD with BILLS
SEC. 2. LYME DISEASE RESEARCH SEMIPOSTAL STAMP. 
(a) IN GENERAL.—To afford a convenient way for 
members of the public to contribute to funding for Lyme 
disease and related tick-borne illness research within the 
National Institute of Allergy and Infectious Diseases, the 
United States Postal Service shall issue a semipostal 
stamp (hereinafter in this Act referred to as the ‘‘Lyme 
Disease Research Semipostal Stamp’’) in accordance with 
this section. 
(b) TERMS AND CONDITIONS.—The issuance and sale 
of the Lyme Disease Research Semipostal Stamp shall be 
governed by the provisions of section 416 of title 39, 
United States Code, and regulations issued under such 
section. 
(c) DISPOSITION OF PROCEEDS.— 
(1) IN GENERAL.—All amounts becoming avail-
able from the sale of the Lyme Disease Research 
Semipostal Stamp (as determined under section 
416(d) of such title 39) shall be transferred to the 
National Institute of Allergy and Infectious Dis-
eases, for the purpose described in subsection (a), 
through payments which shall be made at least twice 
a year. 
(2) PROCEEDS NOT TO BE OFFSET.—In accord-
ance with section 416(d)(4) of such title 39, 
amounts becoming available from the sale of the 
VerDate Sep 11 2014 
23:06 Nov 15, 2017
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4333.IH
H4333
daltland on DSK30NT082PROD with BILLS
Lyme Disease Research Semipostal Stamp (as so de-
termined) shall not be taken into account in any de-
cision relating to the level of appropriations or other 
Federal funding to be furnished in any year to the 
National Institute of Allergy and Infectious Dis-
eases. 
(d) 
DURATION.—The 
Lyme 
Disease 
Research 
Semipostal Stamp shall be made available to the public 
for a period of at least 6 years, beginning no later than 
12 months after the date of the enactment of this Act. 
(e) DEFINITION.—For purposes of this Act, the term 
‘‘semipostal stamp’’ refers to a stamp described in section 
416(a)(1) of title 39, United States Code. 
Æ 
VerDate Sep 11 2014 
23:06 Nov 15, 2017
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H4333.IH
H4333
daltland on DSK30NT082PROD with BILLS